# Mechanism of Action
**Permanently  [[COX#1]]** via acetylation →
- ↓↓ production of **[[TXA2]]** ⊣ [[Platelet Aggregation]]
- Others [[NSAIDs]] stuff

> COX-1 also produces PGI2 which inhibit platelet aggregation
> 
> **COX-1 in the [[Endothelial Cells]]** (which produces [[PGI2]]) has **lower sensitivity** →  q given at **low-dose** → **affects COX-1 in [[Platelet]] only** ( TXA2)
> 
> Also, platelets have no nucleus → cannot synthesize new COX-1 q endothelial cells can

# Clinical Usage
**Low dose** — 65, 75 or 81 mg/day for chronic use
- Secondary prevention
    - **[[Myocardial Infarction]]**
    - **[[Stroke#Ischaemic]]**
- **Combined c [[Anticoagulants]]** -- pt c [[Artificial Heart Valves]]

**Analgesic dose** — 325 mg -- **Acute situations**, e.g., Acute [[Myocardial Infarction]]

> Long duration of action → 7-10 d as platelet lifespan

# Side Effects
- [[Abdominal Discomfort]] -- [[Nausea & Vomiting]], [[Gastrin]], etc.
- [[Stroke#Haemorrhagic]]

# Contraindication
- **Aspirin intolerance**
- **[[Haemophilia]]**
- History of **[[GI Bleeding]]**, [[Peptic Ulcer Disease]], etc.
- **[[Gout]]** — aspirin ⊣ secretion of [[Uric Acid]]
- Retinal haemorrhage

